Safety and Immunogenicity of CHIKV VLP Vaccine PXVX0317 in Adults ≥65 Years
Public ClinicalTrials.gov record NCT05349617. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3 Safety and Immunogenicity Trial of the VLP-Based Chikungunya Virus Vaccine PXVX0317 in Adults ≥65 Years of Age
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this phase 3, randomized, double-blind, placebo-controlled study is to evaluate the safety and immunogenicity to PXVX0317 in adults ≥65 years of age.
Study identification
- NCT ID
- NCT05349617
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 413 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 65 Years and older
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 12, 2022 (Actual)
- Primary completion
- Jun 19, 2023 (Actual)
- Completion
- Aug 8, 2023 (Actual)
- Last update posted
- Dec 13, 2024
2022 – 2023
United States locations
- U.S. sites
- 10
- U.S. states
- 6
- U.S. cities
- 10
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Suncoast Research Associates, LLC | Miami | Florida | 33173 | — |
| Panax Clinical Research | Miami Lakes | Florida | 33014 | — |
| Global Clinical Research Professionals (GCP) | St. Petersburg | Florida | 33705 | — |
| AMR Kansas City | Kansas City | Missouri | 64114 | — |
| Rochester Clinical Research, Inc. | Rochester | New York | 14609 | — |
| Coastal Carolina Research Center | North Charleston | South Carolina | 29405 | — |
| DM Clinical Research CyFair | Houston | Texas | 77065 | — |
| BHFC Research | San Antonio | Texas | 78249 | — |
| DM Clinical Research Tomball | Tomball | Texas | 77375 | — |
| Spaulding Clinical | West Bend | Wisconsin | 53095 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05349617, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 13, 2024 · Synced Oct 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT05349617 live on ClinicalTrials.gov.